Wegener's Granulomatosis & Microscopic Polyangitis

Managing GPA and MPA for Better Health

Wegener's Granulomatosis (now called Granulomatosis with Polyangiitis - GPA) and Microscopic Polyangiitis (MPA) are rare autoimmune vasculitic diseases that cause inflammation of small to medium-sized blood vessels. These conditions can affect organs such as the lungs, kidneys, sinuses, and skin. GPA often presents with sinus issues, cough, and nosebleeds, while MPA commonly leads to kidney problems and fatigue. Early diagnosis is critical to reduce organ damage and improve outcomes through timely treatment.

Common symptoms may include chronic sinusitis, shortness of breath, persistent cough, hematuria (blood in urine), skin rashes, and joint pain. Treatment generally involves high-dose corticosteroids and immunosuppressants like cyclophosphamide or rituximab. In some cases, plasma exchange may be used. Regular monitoring is essential to manage disease activity, prevent relapses, and minimize medication side effects, helping patients maintain long-term health and quality of life.

Wegener's Granulomatosis & Microscopic Polyangiitis Symptoms

Wegener’s Granulomatosis (GPA) and Microscopic Polyangiitis (MPA) are rare autoimmune vasculitides causing inflammation in blood vessels and affecting vital organs like lungs and kidneys.

• Chronic sinus issues or nasal congestion with frequent nosebleeds and crusting.
• Shortness of breath, coughing, or coughing up blood due to lung inflammation.
• Fatigue, fever, and unexplained weight loss as part of systemic symptoms.
• Blood in urine or foamy urine caused by kidney involvement in vasculitis.
• Joint pain or skin rashes including red or purplish spots from vessel damage.

Diagnosis

Diagnosing Wegener’s Granulomatosis and Microscopic Polyangiitis involves clinical evaluation, laboratory tests, imaging, and sometimes biopsy to confirm small-vessel vasculitis and organ involvement.

• Doctors assess symptoms like sinusitis, cough, hematuria, and skin rashes.
• Blood tests often show elevated ESR, CRP, and signs of inflammation.
• ANCA testing helps detect c-ANCA in GPA or p-ANCA in MPA patients.
• CT scans evaluate lung nodules, sinus involvement, or infiltrates.
• Urinalysis may show blood or protein due to kidney vasculitis damage.
• Tissue biopsy confirms diagnosis by showing granulomas or necrotizing vasculitis.

Treatment Options

Although there is no cure for GPA or MPA, aggressive treatment can reduce inflammation, prevent relapse, and protect organs from long-term damage.

• Corticosteroids like prednisone are used to suppress inflammation and reduce symptoms.
• Immunosuppressants such as cyclophosphamide or rituximab are used to induce remission.
• Maintenance drugs like azathioprine or methotrexate help prevent disease recurrence.
• Physical therapy improves strength, reduces fatigue, and supports overall function.
• Regular monitoring assesses organ health, medication response, and flare prevention.

Therapy & Surgery

Supportive therapies and long-term care play a key role in managing fatigue, restoring function, and improving quality of life in GPA and MPA.

• Physical therapy helps rebuild strength, reduce fatigue, and support daily activities.
• Pulmonary rehab may be needed for breathing issues caused by lung involvement.
• Occupational therapy aids in conserving energy and adapting home or work tasks.